MIGS has no lasting effect on anterior segment parameters

Article

Implantation of the Ex-PRESS miniature device has been found to have no lasting effects on anterior segment parameters, according to recently published data in the Journal of Glaucoma.

Implantation of the Ex-PRESS miniature device has been found to have no lasting effects on anterior segment parameters, according to recently published data in the Journal of Glaucoma.

The study led by Dr Na’ama Hammel (Department of Ophthalmology, Rabin Medical Center, Petah-Tiqva, Israel) analysed 19 eyes of 19 patients to evaluate if the Ex-PRESS miniature glaucoma implant surgery would affect corneal curvature and anterior segment parameters.

The team used the Pentacam rotating Scheimpflug camera (Oculus Inc.) to analyse the eyes preoperatively and then at 1 day, 1 week, 1 month and 3 months postoperatively to determine if there were any changes in parameters. Measurements were taken of the anterior and posterior corneal curvature, anterior and posterior corneal astigmatism, anterior chamber depth (ACD), anterior chamber volume (ACV) and anterior chamber angle before and after surgery.

One day after surgery and at 3 months post-op, the intraocular pressure (IOP) was found to reduce to a statistically significant level. The anterior corneal astigmatism and posterior corneal astigmatism increased, and the ACD and ACV both decreased on the first post-op day. However, at 3 months post-op these changes in anterior segment parameters were not found to be statistically significant.

For more detailed information please view the abstract here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.